GlycoMimetics prices $119m public offering

GlycoMimetics (NSDQ:GLYC) priced an underwritten public offering of 7,000,000 shares of common stock at $17.00 apiece today, reporting that it expects to bring in $119 million from the offering. The Rockville, Md.-based company plans to offer underwriters a 30-day option to buy an additional 1,050,000 shares of common stock at the same price. Get the full story at our sister site, Drug Delivery Business News. The post GlycoMimetics prices $119m public offering appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Funding Roundup Oncology Pharmaceuticals glycomimetics Source Type: news